Purchase Order 75N90019P00534

<p>The NIH Clinical Center awarded a purchase order to Immucor Inc. on June 21, 2017, with a ceiling value of $6,035.65 for in vitro diagnostic products and blood banking supplies. Performance is located in Bethesda, Maryland, with an ultimate completion date of July 21, 2017. The order is firm fixed-price with no set-aside designation.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Immucor Inc. on October 19, 2017, with a ceiling value of $6,462.79 for in vitro diagnostic products and blood banking supplies. Performance is located in Bethesda, Maryland, with an ultimate completion date of November 3, 2017. The order is priced on a firm fixed-price basis and carries no set-aside designation.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Immucor Inc. on February 7, 2018, valued at $4,970.47, with completion on March 7, 2018. The order carries no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order is firm fixed price for in vitro diagnostic products, reagents, or blood banking supplies supporting federal healthcare operations.</p>

<p>The NIH Clinical Center awarded a purchase order to Immucor Inc. for $4,245.99 on November 6, 2017, with completion by November 30, 2017. No set-aside was used. Place of performance is Bethesda, Maryland. The order procures in vitro diagnostic products, reagents, and blood banking supplies for medical testing and transfusion compatibility operations at the federal healthcare facility.</p>

<p>The NIH Clinical Center awarded a purchase order to Immucor Inc. on July 24, 2019, with a ceiling value of $13,279.50 for in vitro diagnostic products and blood banking supplies. Performance is at Immucor's facility in Norcross, Georgia. The order is firm fixed price with no small business set-aside.</p>

<p>The NIH Clinical Center awarded a purchase order to Immucor Inc. on July 20, 2015, for $4,291.60, with final completion on March 18, 2021. No set-aside applied. Performance is located in Bethesda, Maryland. The order procures in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. Immucor is a for-profit manufacturer of blood banking solutions and related consumables serving federal healthcare agencies.</p>

<p>The National Institutes of Health Clinical Center issued a delivery order to Immucor Inc. on January 18, 2026, with a ceiling value of $11,053.97 under GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed price with an ultimate completion date of January 31, 2026. No set-aside was used.</p>

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm fixed price purchase order for $16,566.11 to Immucor Inc. to fulfill a requirement for reagents. The contract has no set-aside designation and is to be completed by September 30, 2024. Immucor is a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. This award positions Immucor to directly supply specialized...

<p>The NIH Clinical Center issued a delivery order to Immucor Inc. on January 16, 2019, with a ceiling value of $15,905.36 under GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests.</p> <p>Immucor manufactures in vitro diagnostic products, reagents, and equipment for blood transfusion and transplantation compatibility testing. Place of performance is Norcross, GA. The order was firm fixed price with an ultimate completion date of February 28, 2020.</p>

This is a delivery order contract awarded by the National Institutes of Health (NIH) Clinical Center to Immucor Inc., a manufacturer of in vitro diagnostic reagents, test kits, and related equipment for blood transfusion and transplantation compatibility testing. The contract, valued at $15,655.11, is a firm-fixed-price order issued under Immucor's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The contract does...